Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,031 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, Not Recruiting

Ibrutinib and Palbociclib in Treating Patients With Previously Treated Mantle Cell Lymphoma

NCT02159755

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • NYP/Weill Cornell Medical Center New York, United States
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis

NCT06046222

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • National Jewish Health Denver, Colorado, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • The Ohio State University Wexner Medical Center Columbus, Ohio, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas

NCT03598998

Conditions
Anaplastic Large Cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, +35 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Active, Not Recruiting

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma

NCT00846742

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • Packard Children's Hospital, Stanford University Palo Alto, California, United States
  • Rady Children's Hospital- San Diego San Diego, California, United States
  • Children's Hospital of Illinois at OSF St. Francis Medical Center Peoria, Illinois, United States
  • Maine Children's Cancer Program (MCCP) Scarborough, Maine, United States
View Trial Details
Active, Not Recruiting

A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)

NCT04628494

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Indiana Blood and Marrow Transplantation Indianapolis, Indiana, United States
  • Community Health Network Cancer Center North Indianapolis, Indiana, United States
  • University of Kentucky Markey Cancer Center Lexington, Kentucky, United States
  • Henry Ford Health System Jackson, Michigan, United States
View all 186 locations
View Trial Details
Active, Not Recruiting

A Study of Real Life Treatment for Multiple Myeloma (MM)

NCT04985643

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Altai Regional Clinical Hospital Barnaul, Altayskiy Kray, Russia
  • Kaluga Regional Clinical Hospital Kaluga, Central Federal District, Russia
  • Smolensk Clinical Hospital of Russian Railways-Medicine Smolensk, Central Federal District, Russia
  • City Clinical Hospital No. 1 named after prof. S.I.Sergeev Khabarovsk, Far Eastern Federal District, Russia
View all 24 locations
View Trial Details

Related conditions